News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2024 Shelley Wood October 01, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Conference News SCAI 2024 CALORI: More Support for Eschewing Fasting Protocols Preprocedure L.A. McKeown May 02, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Daily News Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA Yael L. Maxwell April 03, 2024
News Daily News Physicians (Mostly) Negative on Private Equity in Healthcare Michael O'Riordan March 13, 2024
Presentation THT 2024 Catheters Are Over-Rated! Heparin as the Primary Option Presenter: Sanjum S. Sethi March 06, 2024
Presentation THT 2024 Catheter Directed Lytics as the Primary Option Presenter: Adnan Khalif March 06, 2024
Presentation THT 2024 Catheter Thrombectomy as the Primary Option Presenter: Kenneth Rosenfield March 06, 2024
News Conference News ISC 2024 ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates Todd Neale February 08, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2024 Shelley Wood February 01, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024